ReviewProgress in molecular biology and translational science2018

Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders.

Lindsay M Lueptow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.